| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00059 | 1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0051 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |